Sarepta Therapeutics News

Sarepta Therapeutics | DEF 14A: Definitive information statements

Apr 24 16:11 ET

Sarepta Therapeutics | DEFA14A: Others

Apr 24 16:05 ET

Sarepta Therapeutics | S-8 POS: S-8 POS

Mar 28 22:33 ET

Sarepta Therapeutics | S-8 POS: S-8 POS

Mar 28 22:33 ET

Sarepta Therapeutics | S-8 POS: S-8 POS

Mar 28 16:25 ET

Sarepta Therapeutics | S-8 POS: S-8 POS

Mar 28 16:18 ET

Sarepta Therapeutics | 8-K: Current report

Jan 8 00:00 ET

Sarepta Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 2, 2023 16:19 ET

Sarepta Therapeutics | 8-K: Current report

Jun 22, 2023 16:49 ET

Sarepta Therapeutics | 8-K: Current report

Jun 22, 2023 14:22 ET

Sarepta Therapeutics | 8-K: Current report

Jun 9, 2023 16:29 ET

Sarepta Therapeutics | DEFA14A: Others

Apr 24, 2023 16:16 ET

Sarepta Therapeutics | DEF 14A: Definitive proxy statements

Apr 24, 2023 16:08 ET

Sarepta Therapeutics | 8-K: Current report

Mar 3, 2023 07:31 ET

Sarepta Therapeutics | 8-K: Current report

Jan 9, 2023 13:40 ET

Sarepta Therapeutics | 8-K: Current report

Dec 13, 2022 17:11 ET

Sarepta Therapeutics | 8-K: Current report

Nov 2, 2022 17:00 ET

Sarepta Therapeutics: Current report

8-K | Sarepta Therapeutics, Inc. (0000873303) (Filer)

Sep 19, 2022 16:31 ET

Sarepta Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 2, 2022 16:14 ET

Sarepta Therapeutics | 8-K: Current report

Jun 3, 2022 16:20 ET